Projects per year
Abstract
ATP is a well-known extracellular signalling molecule and neurotransmitter known to activate purinergic P2X receptors. Information has been elucidated about the structure and gating of P2X channels following the determination of the crystal structure of P2X4 (zebrafish), however there is still much to discover regarding the role of this receptor in the central nervous system (CNS). In this review we provide an overview of what is known about P2X4 expression in the CNS and discuss evidence for pathophysiological roles in neuroinflammation and neuropathic pain. Recent advances in the development of pharmacological tools including selective antagonists (5-BDBD, PSB-12062, BX430) and positive modulators (ivermectin, avermectins, divalent cations) of P2X4 will be discussed.
Original language | English |
---|---|
Article number | 291 |
Journal | Frontiers in Pharmacology |
Volume | 8 |
DOIs | |
Publication status | Published - 23 May 2017 |
Keywords
- ATP
- P2X receptor
- P2X4 receptor
- Ivermectin
- Microglial cells
- Neuroinflammation
- Pain
- Pharmacology
Profiles
-
Samuel Fountain
- School of Biological Sciences - Professor of Pharmacology
- Cells and Tissues - Member
Person: Research Group Member, Academic, Teaching & Research
-
Leanne Stokes
- School of Chemistry, Pharmacy and Pharmacology - Associate Professor in Pharmacology
- Molecular and Tissue Pharmacology - Member
Person: Research Group Member, Academic, Teaching & Research
Projects
- 1 Finished